Abstract:Human RecQ deconjugating enzyme WRN is involved in DNA replication, DNA repair, recombination, transcription and telomere stabilization[1]. It plays a key role in nucleic acid metabolism as well. WRN defects lead to premature aging, type II diabetes, osteoporosis, atherosclerosis and cancer[2]. Hence it is of great interest of both pharmaceutical and academic field to develop the WRN inhibitors. Here we constructed an integrated experimental cascade, which contains both in vitro and in vivo assays, to conduct the high throughput hit-to-lead compound screen. WRN proteins of different length have been successfully purified and utilized to develop multiple biochemical assays such as unwinding assay and ATPase assay. We have also validated different cellular assays, including proliferation and immunofluorescence, to assess the cytotoxicity and the influence of downstream biomarkers of WRN inhibitors. A WRN knock-out cell line has been generated to better appreciate the inhibition mechanism. In addition, we have generated a WRN-HiBiT knock-in cell line to evaluate WRN degraders or target-compound interactions. Lastly, multiple CDX models utilizing different MSI or MSS cell lines have been validated to help determine the efficacy of WRN inhibitors thus shed light on the drug indications. Together our WRN screening cascade can provide comprehensive compound evaluation across in vitro and in vivo platforms, thus serve as an efficient screening platform for new drug discovery. [1] Kitano K. Structural mechanisms of human RecQ helicases WRN and BLM. Front Genet. 2014 Oct 29;5:366. [2]Hussain M, Krishnamurthy S, Patel J, Kim E, Baptiste BA, Croteau DL, Bohr VA. Skin Abnormalities in Disorders with DNA Repair Defects, Premature Aging, and Mitochondrial Dysfunction. J Invest Dermatol. 2021 Apr;141(4S):968-975. Citation Format: Aicheng Wang, Kejun Mao, Tao Li, Lizhao Guan, Yuhong Chen, Haiting Dai, Xian Wu, Jiabao Lv, Xu Wang, Cong Huang, Tiejun Bing. A WRN screening cascade to facilitate novel drug discovery [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5609.

Acetylation of WRN Protein Regulates Its Stability by Inhibiting Ubiquitination.

Acetylation of Werner Syndrome Protein (WRN): Relationships with DNA Damage, DNA Replication and DNA Metabolic Activities

Regulation of Wrn Protein Cellular Localization and Enzymatic Activities by Sirt1-Mediated Deacetylation

UV-Induced RPA1 Acetylation Promotes Nucleotide Excision Repair.

Acetylation of 53BP1 Dictates the DNA Double Strand Break Repair Pathway

hnRNPA2B1 deacetylation by SIRT6 restrains local transcription and safeguards genome stability

Proper RPA acetylation promotes accurate DNA replication and repair

Werner syndrome RECQ helicase participates in and directs maintenance of the protein complexes of constitutive heterochromatin in proliferating human cells

Chfr and RNF8 Synergistically Regulate ATM Activation

Acetylation-dependent Function of Human Single-Stranded DNA Binding Protein 1

Acetylation Promotes TyrRS Nuclear Translocation to Prevent Oxidative Damage

Ubiquitylation of Rad51d Mediated by E3 Ligase Rnf138 Promotes the Homologous Recombination Repair Pathway.

Acetylation Of P53 Inhibits Its Ubiquitination By Mdm2

Site-specific acetylation of polynucleotide kinase 3'-phosphatase (PNKP) regulates its distinct role in DNA repair pathways

MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner

Acetylation of MLH1 by CBP increases cellular DNA mismatch repair activity

Site-specific acetylation of polynucleotide kinase 3′-phosphatase regulates its distinct role in DNA repair pathways

Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair

Acetylation Dependent Translocation of EWSR1 Regulates CHK2 Alternative Splicing in Response to DNA Damage

WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis

Abstract 5609: A WRN screening cascade to facilitate novel drug discovery